지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2024.7
- 수록면
- 838 - 846 (9page)
- DOI
- 10.4143/crt.2023.886
이용수
초록· 키워드
오류제보하기
Purpose The locally advanced unresectable intrahepatic cholangiocarcinoma (ICC) has detrimental oncological outcomes. In this study, we aimed to investigate the efficacy of radiotherapy in patients with locally advanced unresectable ICC.
Materials and Methods Between 2001 and 2021, 116 patients were identified through medical record who underwent radiotherapy for locally advanced unresectable ICC. The resectability of ICC is determined by the multidisciplinary team at each institution. Overall survival (OS) were analyzed using the Kaplan-Meier method, and prognostic factors were analyzed using the Cox proportional hazards model.
Results The median equivalent radiotherapy dose in 2 Gy fractions (EQD2) was 52 Gy (range, 30 to 110 Gy). Forty-seven patients (40.5%) received sequential gemcitabine-cisplatin based chemotherapy (GEM-CIS CTx). Multivariate analysis identified two risk factors, EQD2 of ≥ 60 Gy and application of sequential GEM-CIS CTx for OS. Patients were grouped by these two risk factors: group 1, EQD2 ≥ 60 Gy with sequential GEM-CIS CTx (n=25); group 2, EQD2 < 60 Gy with sequential GEM-CIS CTx or fluoropyrimidine-based concurrent chemoradiotherapy (n=70); and group 3, radiotherapy alone (n=21). Curative resection was more frequently undergone in group 1 than in groups 2 or 3 (28% vs. 8.6% vs. 0%, respectively). Consequently, OS was significantly better in group 1 than in groups 2 and 3 (p < 0.05).
Conclusion Combined high-dose radiotherapy with sequential GEM-CIS CTx improved oncologic outcomes in patients with locally advanced unresectable ICC. Further prospective studies are required to validate these findings.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Gemcitabine Combined with Capecitabine Compared to Gemcitabine with or without Erlotinib as First-Line Chemotherapy in Patients with Advanced Pancreatic Cancer
Cancer Research and Treatment
2015 .01
-
CTx might Take Over RT
대한외과학회 학술대회 초록집
2018 .11
-
Role of Adjuvant Thoracic Radiation Therapy and Full Dose Chemotherapy in pN2 Non-small Cell Lung Cancer: Elucidation Based on Single Institute Experience
Cancer Research and Treatment
2017 .01
-
Induction Chemotherapy with Gemcitabine and Cisplatin Followed by Simultaneous Integrated Boost–Intensity Modulated Radiotherapy with Concurrent Gemcitabine for Locally Advanced Unresectable Pancreatic Cancer: Results from a Feasibility Study
Cancer Research and Treatment
2017 .01
-
Feasibility and Efficacy of Concurrent Chemoradiotherapy in Elderly Patients with Esophageal Squamous Cell Carcinoma: a Respective Study of 116 Cases from a Single Institution
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Surgery Alone Versus Surgery Followed by Chemotherapy and Radiotherapy in Resected Extrahepatic Bile Duct Cancer: Treatment Outcome Analysis of 336 Patients
Cancer Research and Treatment
2016 .01
-
Occurrence of CTX-M-producing Escherichia coli from in broilers with colibacillosis
예방수의학회지
2022 .09
-
Decision on Chemotherapy Amidst COVID-19 Pandemic: a Review and a Practical Approach from Iran
Infection and Chemotherapy
2020 .01
-
Significant Efficacy of Additional Concurrent Chemotherapy with Radiotherapy for Postoperative Cervical Cancer with Risk Factors: a Systematic Review and Meta-analysis
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Optimal dose and volume for postoperative radiotherapy in brain oligometastases from lung cancer: a retrospective study
Radiation oncology journal : ROJ
2017 .01
-
Impact of radiation dose on concurrent chemoradiotherapy for limited-stage small-cell lung cancer
Radiation oncology journal : ROJ
2018 .01
-
Oncologic Outcomes of Postoperative Chemoradiotherapy Versus Chemotherapy Alone in Stage II and III Upper Rectal Cancer
Annals of Coloproctology
2019 .01
-
Clinical Feasibility of Curative Surgery after nab-Paclitaxel Plus Gemcitabine-cisplatin Chemotherapy in Patients with Locally Advanced Cholangiocarcinoma
대한외과학회 학술대회 초록집
2022 .11
-
Analysis of Once-Daily Thoracic Radiotherapy Dose According to the Underlying Lung Disease in Patients with Limited-Stage Small Cell Lung Cancer Undergoing Concurrent Chemoradiotherapy
Cancer Research and Treatment
2023 .01
-
Focus on The Radiotherapy
대한외과학회 학술대회 초록집
2019 .10
-
An Updated Meta-analysis and System Review:is Gemcitabine+Fluoropyrimidine in Combination a Better Therapy Versus Gemcitabine Alone for Advanced and Unresectable Pancreatic Cancer?
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
CTX-M 광범위 베타락탐 분해효소의 그룹별 내성표현형 차이
Annals of Clinical Microbiology
2019 .01
-
반려동물에서 분리된 cefotaxime 내성 그람 음성균에서 CTX-M β-lactamase와 plasmid 매개 퀴놀론 내성 유전자
한국가축위생학회지
2020 .01
-
Successful radical surgery after neoadjuvant chemotherapy for locally advanced intrahepatic cholangiocarcinoma
대한외과학회 학술대회 초록집
2019 .10
-
Surgical Resection after Gemcitabine, Cisplatin, and Nab-Paclitaxel Chemotherapy for Locally Advanced Cholangiocarcinoma: A Retrospective Single-Center Study
대한외과학회 학술대회 초록집
2021 .05
최근 본 자료
댓글(0)
0